Breaks Categories: Stock Spotlights

FridayAug 03, 2018 1:10 pm

CannabisNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Set to Reach Full Value of Assets via Planned Spinoff

Vertically integrated cannabis company Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) recently revealed its plans to spinoff its Canadian assets to attain the full value of its resources in both the US and Canada. The resulting Canadian assets will then be listed on the Toronto Stock Exchange and Nasdaq. A recent article discussing the company reads: “Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a vertically integrated medical cannabis company headquartered in Vancouver, Canada, and operating in the world’s two largest cannabis markets – Canada and California – is reaping positive attention with the news that the company intends to spin off its…

Continue Reading

WednesdayJul 25, 2018 2:42 pm

CannabisNewsBreaks – Sunniva Inc.’s (CSE: SNN) (OTCQX: SNNVF) Vertically Integrated Structure Strengthened by Several Subsidiaries

Vertically integrated cannabis company Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), through several wholly-owned subsidiaries, has operations in cannabis grow facilities, cannabis extraction facilities, medical cannabis clinics and the cannabis white label business. A recent article discussing the company reads: “Sunniva’s seed-to-sale, vertically integrated structure is also bolstered by its Full Scale Distributers (“FSD”) subsidiary, which markets vaporizers and accessories under the Vapor Connoisseur brand. FSD also provides white label packaging and labelling services to over 80 brands in North America, making it a clear leader in the space. It will design custom vapor hardware for any specification of cannabis oil…

Continue Reading

FridayJul 20, 2018 11:38 am

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Platform Continues to Demonstrate its Value

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) believes that in the future, up to 80 percent of its total revenue could stem from licensing deals for its patented DehydraTECH™ delivery technology. An article discussing the company reads: “The company’s patented DehydraTECH™ is key to LXRP’s valuation. The technology is being tested in human clinical studies for the delivery of cannabinoids through ingestible means. Results thus far have shown increased absorption rates with reduced time to enter the bloodstream and reported improvements in the taste and smell of edible products. … Lab tests on mice have shown a 50 percent improvement in…

Continue Reading

MondayJul 16, 2018 3:01 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Delivers Groundbreaking, Organic Options to Preventive Healthcare Market

PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) aims to be a leader in the preventive health sciences and provide revolutionary options for preventive and curative therapies utilizing organic products. An article discussing the company reads: “PreveCeutical currently has five research and development programs, including dual gene therapy for curative and prevention therapies for diabetes and obesity. The World Health Organization (WHO) states that some 425 million people around the world are living with diabetes, and that number is projected to rise to 629 million by 2045. Treating diabetes is a costly matter, both economically and in terms of physical…

Continue Reading

FridayJul 13, 2018 11:46 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Maintains Robust Suite of Products, Strong IP Portfolio

Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is engaged in the development and commercialization of quality cannabinoid-based nutraceuticals and pharmaceuticals by utilizing unique drug delivery platform technologies. An article discussing the company reads: “Pivot Pharmaceuticals has a suite of 30 products ready for commercialization. The company also has a strong intellectual property (“IP”) portfolio for the formulation and delivery of cannabinoids. Pivot’s proposed product line comprises capsules and tablets, bulk powder, stick packs and beverages. Its product line also consists of water soluble oral solutions, lotions, creams, gels and pet supplements. … Pivot Pharmaceuticals has acquired the global rights…

Continue Reading

FridayJul 13, 2018 10:47 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Potential in Alternative Nicotine Delivery Method

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) believes that its patented technology, DehydraTECH™ has the potential to transform nicotine use by offering a delivery method that may be an effective alternative to the traditional inhalation. An article discussing the company reads: “Although inhalation is an effective delivery mechanism – much more so than non-enhanced edible ingestion – it is dangerous. The toxins released during combustion are harmful and can potentially kill the user. Edible ingestion eliminates the toxins caused by lighting up. While inhalation is fast, traditionally, ingestion has not been. However, the use of DehydraTECH™ speeds things up to make…

Continue Reading

FridayJul 06, 2018 11:29 am

CannabisNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Subsidiary Advances in Canadian Cannabis Market

Vertically integrated cannabis company Sunniva’s (CSE: SNN) (OTCQX: SNNVF) wholly-owned subsidiary, Sunniva Medical Inc. (“SMI”), received a Confirmation of Readiness (“COR”) notification from Health Canada recently. Attaining the COR is a key step toward SMI receiving a license to produce. A recent article discussing the company reads: “The COR received by Sunniva Medical Inc. (SMI) was issued under new rules instituted in May 2017 by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR), which removed the necessity for a physical inspection of grow facilities prior to the issuance of a cultivation license. The new regime allows…

Continue Reading

FridayJul 06, 2018 10:13 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Out-licenses Disruptive Delivery Technology to Strategically Build Cash Flow

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) has been strategically out-licensing its disruptive delivery technology and focusing on R&D to improve its value and increase cash flow. An article further discussing the company reads: “Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Chris Bunka said in a recent CFN Media Group interview that his company has gained in value and cash flow, purposely keeping its cash burn rate down and evaluating technology applications for both cannabis and other sectors (http://cnw.fm/4MDyw). … Bunka explained that LXRP is respecting its shareholders in terms of lowered spending and increasing its valuation, purposely maintaining its…

Continue Reading

ThursdayJul 05, 2018 3:07 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Conducts Extensive Research on Sol-gel CBD-based Delivery System

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is presently working on the advancement of its Sol-gel drug delivery research program. An article discussing the company reads: “Currently, the company’s research is focused on testing various cannabis strains for the purpose of formulating potent and effective Sol-gels. PreveCeutical Chief Research Officer Dr. Harendra Parekh is leading the program. … In addition, various spray devices have already been tested. According to PreveCeutical CEO and President Stephen Van Deventer, a focus on safety regulations and a tamper-proof delivery system will be of paramount importance. While the Sol-gel program…

Continue Reading

MondayJul 02, 2018 11:55 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc.’s (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) RTIC Powder Opens Doors for Supply Contracts

Pivot Pharmaceuticals’ (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) patented Ready To Infuse Cannabis (“RTIC”) powder is drawing the attention of respected cannabis brands in California, resulting in potential manufacturing and supply agreements for the company. An article further discussing the company reads: “Pivot’s RTIC process and Solmic Micelle water-soluble technologies will be used to generate a dry cannabis powder that can be used as a baking additive, in pet products and in a variety of retail items. Part of the manufacturing facility will be used to produce topical creams and oral drug delivery technologies, but, at the moment, one of…

Continue Reading